MedPath
NMPA Approval

Ozanimod Hydrochloride Capsules

国药准字HJ20230004

January 31, 2023

Drug Information

盐酸奥扎莫德胶囊

热珀西亚

胶囊剂

0.23mg(按C₂₃H₂₄N₄O₃计)

化学药品

January 31, 2023

January 30, 2028

Company Information

Applicant Company

Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867, Ireland

Manufacturing Company

Route de Perreux 1, Boudry, 2017, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸奥扎莫德胶囊 - NMPA 批准文号 | MedPath